VECTORS CONTAINING SPACER/FILLER POLYNUCLEOTIDE SEQUENCES, AND METHODS OF USING THEM Russian patent published in 2020 - IPC C12N15/00 C12N15/86 A61K39/23 

Abstract RU 2725813 C2

FIELD: biotechnology.

SUBSTANCE: described is a recombinant vector plasmid for transferring and delivering a heterogeneous polynucleotide sequence into a mammalian cell, comprising: an adeno-associated virus (AAV) vector genome containing a heterologous polynucleotide sequence and an expression control sequence, which triggers a transcription of the heterologous polynucleotide sequence; and main sequence, containing a first inert polynucleotide filler sequence or a spacer polynucleotide sequence, wherein said heterologous polynucleotide sequence in length is less than 4.7 Kb and is located between two sequences of inverted end repeat (ITR) adenoassociated virus (AAV), wherein said first inert polynucleotide filler sequence or spacer polynucleotide sequence is located outside the ITR AAV and has length of 4.5–10 Kb or 6–8 Kb and where length of said main sequence is at least 7.0 Kb. Said heterologous polynucleotide codes a protein which provides therapeutic benefit, or encodes an inhibitory nucleic acid, which reduces or inhibits expression of an undesired or defective gene.

EFFECT: invention reduces impurities of residual plasmid DNA.

42 cl, 6 dwg, 3 ex

Similar patents RU2725813C2

Title Year Author Number
VARIANT AAV, COMPOSITIONS AND METHODS, IN WHICH IT IS USED, AS WELL AS METHODS OF ITS APPLICATION FOR TRANSFER OF GENES INTO CELLS, ORGANS AND TISSUES 2014
  • Khaj Ketrin A.
  • Yazisioglu Mustafa N.
  • Angela Khaver
RU2697444C2
AAV VECTOR AND NEUTRALIZING ANTIBODIES AGAINST AAV (ADENO-ASSOCIATED VIRUS) ANALYSIS 2014
  • Khaj Ketrin A.
  • Mingozzi Federiko
  • Chen Ifyn
RU2705249C2
MODIFIED FACTOR IX, AS WELL AS COMPOSITIONS, METHODS AND OPTIONS FOR THE USE OF GENE TRANSFER INTO CELLS, ORGANS AND TISSUE 2016
  • Khaj Ketrin A.
  • Angela Khaver
RU2811445C2
RNAi AGENT OPTION 2018
  • O'Riordan, Catherine R.
  • Palermo, Adam
  • Richards, Brenda
  • Stanek, Lisa M.
RU2789647C2
SCALABLE METHODS FOR OBTAINING RECOMBINANT VECTOR BASED ON ADENO-ASSOCIATED VIRUS (AAV) IN SYSTEM OF SERUM-FREE SUSPENSION CELL CULTURE, SUITABLE FOR CLINICAL USE 2016
  • Qu, Guang
  • Lu, Lin
  • Wright, John Fraser
RU2766583C2
MODIFIED ADENO-ASSOCIATED VIRUS VECTOR COMPOSITIONS 2013
  • Devidson, Beverli, L.
  • Shchil, Mariya
  • Budro, Rajan
  • Mas Montejs, Alekhandro
RU2679843C2
PROMOTER COMPOSITIONS 2014
  • Dejvidson Beverli L.
  • Rodrigez Edgardo
  • Mas Montejs Alekhandro
RU2742435C2
AMPLIFIER AGENTS TO INCREASE CELL TRANSFECTION AND/OR rAAV VECTOR PRODUCTION 2018
  • Qu, Guang
  • Lu, Lin
  • Josue-Almqvist, Jesusa
  • Wright, John Fraser
RU2802520C2
COMPLETELY SCALABLE METHOD FOR PRODUCING rAAV BASED ON COLUMNS 2017
  • Qu, Guang
  • Oh, Younghoon
  • Lu, Lin
  • Wright, John Fraser
RU2754467C2
COMPOSITIONS AND METHODS OF TREATING AND PREVENTING MACULAR DEGENERATION 2015
  • Skaria Abrakham
RU2703145C2

RU 2 725 813 C2

Authors

Rajt Dzh. Frejzer

Zelenaya Olga

Dates

2020-07-06Published

2014-03-14Filed